{"title":"白细胞中Y染色体缺失与主要心血管事件。","authors":"Jan P Dumanski, Johan Sundström, Lars A Forsberg","doi":"10.1161/CIRCGENETICS.117.001820","DOIUrl":null,"url":null,"abstract":"It has been observed for centuries that men have a shorter lifespan than women. The current difference globally is on average 4 years, and the difference is even larger in populations with longer life expectancy, for example, ≈6 years in the European Union and 7 years in Japan.1 A larger difference in populations with higher longevity suggests that the underlying factors are stronger in populations with a large part of the mortality related to age-associated diseases. Cardiovascular diseases are the leading causes of death globally and are increasing.2 The share of total mortality that is because of cardiovascular diseases is similar in both sexes, but men fall ill and die from it at a younger age. Cardiovascular disease risk factors are equally important for men and women.3 Hence, the age differences in incidence and mortality between men and women are because of other reasons than differential environmental risk factor exposures. Recent discoveries on pathological effects from a male-specific genetic risk factor—loss of chromosome Y (LOY) in blood cells—can partly explain the observed sex difference in longevity. Analyses by Haitjema et al4 in this issue of Circulation: Cardiovascular Genetics describe a previously unknown association between LOY in blood cells and major cardiovascular events.\n\nSee Article by Haitjema et al \n\nA high prevalence …","PeriodicalId":10277,"journal":{"name":"Circulation: Cardiovascular Genetics","volume":"10 4","pages":"e001820"},"PeriodicalIF":0.0000,"publicationDate":"2017-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1161/CIRCGENETICS.117.001820","citationCount":"7","resultStr":"{\"title\":\"Loss of Chromosome Y in Leukocytes and Major Cardiovascular Events.\",\"authors\":\"Jan P Dumanski, Johan Sundström, Lars A Forsberg\",\"doi\":\"10.1161/CIRCGENETICS.117.001820\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"It has been observed for centuries that men have a shorter lifespan than women. The current difference globally is on average 4 years, and the difference is even larger in populations with longer life expectancy, for example, ≈6 years in the European Union and 7 years in Japan.1 A larger difference in populations with higher longevity suggests that the underlying factors are stronger in populations with a large part of the mortality related to age-associated diseases. Cardiovascular diseases are the leading causes of death globally and are increasing.2 The share of total mortality that is because of cardiovascular diseases is similar in both sexes, but men fall ill and die from it at a younger age. Cardiovascular disease risk factors are equally important for men and women.3 Hence, the age differences in incidence and mortality between men and women are because of other reasons than differential environmental risk factor exposures. Recent discoveries on pathological effects from a male-specific genetic risk factor—loss of chromosome Y (LOY) in blood cells—can partly explain the observed sex difference in longevity. Analyses by Haitjema et al4 in this issue of Circulation: Cardiovascular Genetics describe a previously unknown association between LOY in blood cells and major cardiovascular events.\\n\\nSee Article by Haitjema et al \\n\\nA high prevalence …\",\"PeriodicalId\":10277,\"journal\":{\"name\":\"Circulation: Cardiovascular Genetics\",\"volume\":\"10 4\",\"pages\":\"e001820\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1161/CIRCGENETICS.117.001820\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Circulation: Cardiovascular Genetics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1161/CIRCGENETICS.117.001820\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation: Cardiovascular Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/CIRCGENETICS.117.001820","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Loss of Chromosome Y in Leukocytes and Major Cardiovascular Events.
It has been observed for centuries that men have a shorter lifespan than women. The current difference globally is on average 4 years, and the difference is even larger in populations with longer life expectancy, for example, ≈6 years in the European Union and 7 years in Japan.1 A larger difference in populations with higher longevity suggests that the underlying factors are stronger in populations with a large part of the mortality related to age-associated diseases. Cardiovascular diseases are the leading causes of death globally and are increasing.2 The share of total mortality that is because of cardiovascular diseases is similar in both sexes, but men fall ill and die from it at a younger age. Cardiovascular disease risk factors are equally important for men and women.3 Hence, the age differences in incidence and mortality between men and women are because of other reasons than differential environmental risk factor exposures. Recent discoveries on pathological effects from a male-specific genetic risk factor—loss of chromosome Y (LOY) in blood cells—can partly explain the observed sex difference in longevity. Analyses by Haitjema et al4 in this issue of Circulation: Cardiovascular Genetics describe a previously unknown association between LOY in blood cells and major cardiovascular events.
See Article by Haitjema et al
A high prevalence …
期刊介绍:
Circulation: Genomic and Precision Medicine considers all types of original research articles, including studies conducted in human subjects, laboratory animals, in vitro, and in silico. Articles may include investigations of: clinical genetics as applied to the diagnosis and management of monogenic or oligogenic cardiovascular disorders; the molecular basis of complex cardiovascular disorders, including genome-wide association studies, exome and genome sequencing-based association studies, coding variant association studies, genetic linkage studies, epigenomics, transcriptomics, proteomics, metabolomics, and metagenomics; integration of electronic health record data or patient-generated data with any of the aforementioned approaches, including phenome-wide association studies, or with environmental or lifestyle factors; pharmacogenomics; regulation of gene expression; gene therapy and therapeutic genomic editing; systems biology approaches to the diagnosis and management of cardiovascular disorders; novel methods to perform any of the aforementioned studies; and novel applications of precision medicine. Above all, we seek studies with relevance to human cardiovascular biology and disease.